Upstream Bio (UPB) Operating Leases (2024 - 2026)

Upstream Bio's Operating Leases history runs 3 years deep, the most recent figure standing at $390000.0 for Q1 2026.

• On a quarterly basis, Operating Leases fell 60.69% year-over-year to $390000.0 in Q1 2026; TTM through Mar 2026 was $390000.0, a 60.69% decrease from a year earlier, with the FY2025 full-year figure at $549000.0, down 51.42% from the prior year.
• Operating Leases retreated to $390000.0 in Q1 2026 per UPB's latest filing, from $549000.0 in the prior quarter.
• Across five years, Operating Leases topped out at $1.3 million in Q3 2024 and bottomed at $390000.0 in Q1 2026.
• The 3-year median for Operating Leases is $849000.0 (2025), against an average of $839428.6.
• Across the five-year window, Operating Leases sank 44.34% in 2025 and plunged 60.69% in 2026, its largest moves.
• Year by year, Operating Leases stood at $1.1 million in 2024, then plunged by 51.42% to $549000.0 in 2025, then decreased by 28.96% to $390000.0 in 2026.
• Per Business Quant, the three latest UPB Operating Leases figures stand at $390000.0 (Q1 2026), $549000.0 (Q4 2025), and $703000.0 (Q3 2025).